paclitaxel has been researched along with Mast Cell Activation Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krell, J; Lythgoe, MP; McNeish, IA; Tookman, L | 1 |
1 other study(ies) available for paclitaxel and Mast Cell Activation Disease
| Article | Year |
|---|---|
Safe administration of chemotherapy in mast cell activation syndrome.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Mastocytosis; Middle Aged; Paclitaxel | 2021 |